Global in Vitro Diagnostics Investment Opportunities

Analysis and Forecasts to 2015

Product Code GMD08298
Publication Date May 2009
Publisher Global Markets Direct
Product Type Report
Pages 384
ISBN Number not applicable
Change currency
PDF £2,530.00 €3,047 $4,001 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Global in Vitro Diagnostics Investment Opportunities

Analysis and Forecasts to 2015

This report is an essential source for key information and data relating to the global in vitro diagnostics market. The report provides global and country level, detailed and comprehensive coverage of market and category revenue, distribution and company share information. It also provides company profiles, pipeline products, news and financial deals in the global in vitro diagnostics market.

Scope

  • This report provides detailed global, regional countries (United States, Germany, United Kingdom, France, Italy, Spain, Japan, Canada, China, India, Australia, Brazil) data on market size by value for in the categories in in vitro diagnostics devices market.
  • It gives key company share information for leading competitors, revenues by distribution channel and forecasts of market values at global and country level.
  • It also provides overview of the market structure, key trends, drivers and restraints, future outlook, competitive landscape and key developments.
  • All figures are based on rigorous research methodologies including in-depth primary and secondary research.

Reasons to buy

  • A single source to fulfill all of your business and competitor intelligence needs
  • Gain a strong understanding of the in vitro diagnostics devices market at a global level, with break downs for 12 countries
  • Evaluate and compare the attractiveness of the market in different geographies.
  • Identify growth segments and opportunities in the industry.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched.
  • Analyze the competitiveness of the market in different countries and regions and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market.
  • Identify and analyze the strengths and weaknesses of the industry incumbents.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in This Report
    • 3.1 In Vitro Diagnostics
    • 3.2 Clinical Chemistry Test Reagents
    • 3.3 Immunochemistry Test Reagents
    • 3.4 Blood Test Reagents
    • 3.5 Microbiology Test Reagents
    • 3.6 Infectious Immunology Test Reagents
    • 3.7 Genetic Test Reagents
    • 3.8 Self Testing
    • 3.9 Instruments
  • 4 In Vitro Diagnostics Cross Country Comparison
  • 5 Global In Vitro Diagnostics Market
    • 5.1 In Vitro Diagnostics, Global, Overall Revenue ($ mn), 2000-2015
    • 5.2 In Vitro Diagnostics, Global, Company share (2006-2007)
  • 6 In Vitro Diagnostics In United States
    • 6.1 In Vitro Diagnostics, United States, Overall Revenue ($ mn), 2000-2015
    • 6.2 In Vitro Diagnostics, United States, Distribution Share (2007-2008)
    • 6.3 In Vitro Diagnostics, United States, Company Share (2006-2007)
  • 7 In Vitro Diagnostics In Germany
    • 7.1 In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015
    • 7.2 In Vitro Diagnostics, Germany, Distribution Share (2007-2008)
    • 7.3 In Vitro Diagnostics, Germany, Company Share (2006-2007)
  • 8 In Vitro Diagnostics In Japan
    • 8.1 In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015
    • 8.2 In Vitro Diagnostics, Japan, Distribution Share (2007-2008)
    • 8.3 In Vitro Diagnostics, Japan, Company Share (2006-2007)
  • 9 In Vitro Diagnostics In France
    • 9.1 In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015
    • 9.2 In Vitro Diagnostics, France, Distribution Share (2007-2008)
    • 9.3 In Vitro Diagnostics, France, Company Share (2006-2007)
  • 10 In Vitro Diagnostics In Italy
    • 10.1 In Vitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015
    • 10.2 In Vitro Diagnostics, Italy, Distribution Share (2007-2008)
    • 10.3 In Vitro Diagnostics, Italy, Company Share (2006-2007)
  • 11 In Vitro Diagnostics In Spain
    • 11.1 In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015
    • 11.2 In Vitro Diagnostics, Spain, Distribution Share (2007-2008)
    • 11.3 In Vitro Diagnostics, Spain, Company Share (2006-2007)
  • 12 In Vitro Diagnostics In China
    • 12.1 In Vitro Diagnostics, China, Overall Revenue ($ mn), 2000-2015
    • 12.2 In Vitro Diagnostics, China, Distribution Share (2007-2008)
    • 12.3 In Vitro Diagnostics, China, Company Share (2006-2007)
  • 13 In Vitro Diagnostics In United Kingdom
    • 13.1 In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015
    • 13.2 In Vitro Diagnostics, United Kingdom, Distribution Share (2007-2008)
    • 13.3 In Vitro Diagnostics, United Kingdom, Company Share (2006-2007)
  • 14 In Vitro Diagnostics In Canada
    • 14.1 In Vitro Diagnostics, Canada, Overall Revenue ($ mn), 2000-2015
    • 14.2 In Vitro Diagnostics, Canada, Distribution Share (2007-2008)
    • 14.3 In Vitro Diagnostics, Canada, Company Share (2006-2007)
  • 15 In Vitro Diagnostics In Brazil
    • 15.1 In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015
    • 15.2 In Vitro Diagnostics, Brazil, Distribution Share (2007-2008)
    • 15.3 In Vitro Diagnostics, Brazil, Company Share (2006-2007)
  • 16 In Vitro Diagnostics In India
    • 16.1 In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015
    • 16.2 In Vitro Diagnostics, India, Distribution Share (2007-2008)
    • 16.3 In Vitro Diagnostics, India, Company Share (2006-2007)
  • 17 In Vitro Diagnostics In Australia
    • 17.1 In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015
    • 17.2 In Vitro Diagnostics, Australia, Distribution Share (2007-2008)
    • 17.3 In Vitro Diagnostics, Australia, Company Share (2006-2007)
  • 18 Overview of Key Companies in Global In Vitro Diagnostics Market
    • 18.1 F. Hoffmann-La Roche Ltd
    • 18.2 Abbott Laboratories
    • 18.3 Dade Behring Holdings, Inc
    • 18.4 bioMerieux S.A
    • 18.5 Siemens Healthcare
    • 18.6 Beckman Coulter, Inc
    • 18.7 Becton, Dickinson and
    • 18.8 Gen-Probe Incorporated
    • 18.9 Genzyme Corporation
    • 18.10 OLYMPUS CORPORATION
    • 18.11 Ortho-Clinical Diagnostics Inc
    • 18.12 Ventana Medical Systems, Inc
    • 18.13 Digene Corporation
    • 18.14 BRAHMS Aktiengesellschaft
    • 18.15 Epigenomics AG
    • 18.16 Epigenomics AG Pipeline Products
    • 18.17 Hain Lifescience GmbH
    • 18.18 Invitek Biotechnolgy & Biodesign Ltd
    • 18.19 Mindray Medical International Limited
    • 18.20 ARKRAY, Inc
    • 18.21 Transasia Bio-Medicals Ltd
    • 18.22 Argene S.A
    • 18.23 Diagnostica Stago
    • 18.24 Beijing Bio-Ekon Biotechnology Co., Ltd
    • 18.25 Beijing Pason Pharmaceuticals Inc
    • 18.26 Jingmei Biotech Co., Ltd
    • 18.27 Autogen Bioclear UK Ltd
    • 18.28 Axis-Shield plc
  • 19 Financial Deals Landscape
    • 19.1 Merger
    • 19.2 Acquisition
    • 19.3 Partnerships
  • 20 Recent Developments
    • 20.1 Strategy and Business Planning
    • 20.2 Legal and Regulatory
    • 20.3 Government and Public Interest
    • 20.4 Product Approvals
  • 21 Appendix
    • 21.1 Global Markets Direct Research Methodology
    • 21.2 Coverage
    • 21.3 Secondary Research
    • 21.4 Primary Research
    • 21.5 Models
    • 21.6 Forecasts
    • 21.7 Expert Panel Validation
    • 21.8 Currency Conversion
    • 21.9 Contact Us
    • 21.10 Disclaimer
  • 1 List of Tables
    • Table 1: In Vitro Diagnostics Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 2: In Vitro Diagnostics, Global, Overall Revenue ($ mn), 2000-2015
    • Table 3: In Vitro Diagnostics, Global, Cross-Category Analysis, 2000-2015
    • Table 4: In Vitro Diagnostics, Global, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 5: In Vitro Diagnostics, Global, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 6: In Vitro Diagnostics, Global, Company share by Revenue ($ mn), 2006-2007
    • Table 7: In Vitro Diagnostics, United States, Overall Revenue ($ mn), 2000-2015
    • Table 8: In Vitro Diagnostics, United States, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 9: In Vitro Diagnostics, United States, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 10: Blood Test Reagents, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 11: Clinical Chemistry Test Reagents, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 12: Genetic Test Reagents, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 13: Immunochemistry Test Reagents, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 14: Infectious Immunology Test Reagents, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 15: Instruments, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 16: Microbiology Test Reagents, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 17: Self Testing, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 18: In Vitro Diagnostics, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 19: Blood Test Reagents, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 20: Clinical Chemistry Test Reagents, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 21: Genetic Test Reagents, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 22: Immunochemistry Test Reagents, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 23: Infectious Immunology Test Reagents, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 24: Microbiology Test Reagents, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 25: Self Testing, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 26: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015
    • Table 27: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 28: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 29: Blood Test Reagents, Germany, Distribution Share by Revenue ($mn), 2007-2008
    • Table 30: Clinical Chemistry Test Reagents, Germany, Distribution Share by Revenue ($mn), 2007-2008
    • Table 31: Genetic Test Reagents, Germany, Distribution Share by Revenue ($mn), 2007-2008
    • Table 32: Immunochemistry Test Reagents, Germany, Distribution Share by Revenue ($mn), 2007-2008
    • Table 33: Infectious Immunology Test Reagents, Germany, Distribution Share by Revenue ($mn), 2007-2008
    • Table 34: Instruments, Germany, Distribution Share by Revenue ($mn), 2007-2008
    • Table 35: Microbiology Test Reagents, Germany, Distribution Share by Revenue ($mn), 2007-2008
    • Table 36: Self Testing, Germany, Distribution Share by Revenue ($mn), 2007-2008
    • Table 37: In Vitro Diagnostics, Germany, Company Share by Revenue ($ mn), 2006-2007
    • Table 38: Blood Test Reagents, Germany, Company Share by Revenue ($ mn), 2006-2007
    • Table 39: Clinical Chemistry Test Reagents, Germany, Company Share by Revenue ($ mn), 2006-2007
    • Table 40: Genetic Test Reagents, Germany, Company Share by Revenue ($ mn), 2006-2007
    • Table 41: Immunochemistry Test Reagents, Germany, Company Share by Revenue ($ mn), 2006-2007
    • Table 42: Infectious Immunology Test Reagents, Germany, Company Share by Revenue ($ mn), 2006-2007
    • Table 43: Microbiology Test Reagents, Germany, Company Share by Revenue ($ mn), 2006-2007
    • Table 44: Self Testing, Germany, Company Share by Revenue ($ mn), 2006-2007
    • Table 45: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015
    • Table 46: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 47: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 48: Blood Test Reagents, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 49: Clinical Chemistry Test Reagents, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 50: Genetic Test Reagents, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 51: Immunochemistry Test Reagents, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 52: Infectious Immunology Test Reagents, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 53: Instruments, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 54: Microbiology Test Reagents, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 55: Self Testing, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 56: In Vitro Diagnostics, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 57: Blood Test Reagents, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 58: Clinical Chemistry Test Reagents, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 59: Genetic Test Reagents, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 60: Immunochemistry Test Reagents, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 61: Infectious Immunology Test Reagents, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 62: Microbiology Test Reagents, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 63: Self Testing, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 64: In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015
    • Table 65: In Vitro Diagnostics, France, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 66: In Vitro Diagnostics, France, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 67: Blood Test Reagents, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 68: Clinical Chemistry Test Reagents, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 69: Genetic Test Reagents, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 70: Immunochemistry Test Reagents, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 71: Infectious Immunology Test Reagents, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 72: Instruments, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 73: Microbiology Test Reagents, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 74: Self Testing, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 75: In Vitro Diagnostics, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 76: Blood Test Reagents, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 77: Clinical Chemistry Test Reagents, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 78: Genetic Test Reagents, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 79: Immunochemistry Test Reagents, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 80: Infectious Immunology Test Reagents, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 81: Microbiology Test Reagents, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 82: Self Testing, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 83: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015
    • Table 84: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 85: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 86: Blood Test Reagents, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 87: Clinical Chemistry Test Reagents, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 88: Genetic Test Reagents, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 89: Immunochemistry Test Reagents, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 90: Infectious Immunology Test Reagents, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 91: Instruments, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 92: Microbiology Test Reagents, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 93: Self Testing, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 94: In Vitro Diagnostics, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 95: Blood Test Reagents, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 96: Clinical Chemistry Test Reagents, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 97: Genetic Test Reagents, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 98: Immunochemistry Test Reagents, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 99: Infectious Immunology Test Reagents, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 100: Microbiology Test Reagents, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 101: Self Testing, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 102: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015
    • Table 103: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 104: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 105: Blood Test Reagents, Spain, Distribution Share by Revenue ($mn), 2007-2008
    • Table 106: Clinical Chemistry Test Reagents, Spain, Distribution Share by Revenue ($mn), 2007-2008
    • Table 107: Genetic Test Reagents, Spain, Distribution Share by Revenue ($mn), 2007-2008
    • Table 108: Immunochemistry Test Reagents, Spain, Distribution Share by Revenue ($mn), 2007-2008
    • Table 109: Infectious Immunology Test Reagents, Spain, Distribution Share by Revenue ($mn), 2007-2008
    • Table 110: Instruments, Spain, Distribution Share by Revenue ($mn), 2007-2008
    • Table 111: Microbiology Test Reagents, Spain, Distribution Share by Revenue ($mn), 2007-2008
    • Table 112: Self Testing, Spain, Distribution Share by Revenue ($mn), 2007-2008
    • Table 113: In Vitro Diagnostics, Spain, Company Share by Revenue ($ mn), 2006-2007
    • Table 114: Blood Test Reagents, Spain, Company Share by Revenue ($ mn), 2006-2007
    • Table 115: Clinical Chemistry Test Reagents, Spain, Company Share by Revenue ($ mn), 2006-2007
    • Table 116: Genetic Test Reagents, Spain, Company Share by Revenue ($ mn), 2006-2007
    • Table 117: Immunochemistry Test Reagents, Spain, Company Share by Revenue ($ mn), 2006-2007
    • Table 118: Infectious Immunology Test Reagents, Spain, Company Share by Revenue ($ mn), 2006-2007
    • Table 119: Microbiology Test Reagents, Spain, Company Share by Revenue ($ mn), 2006-2007
    • Table 120: Self Testing, Spain, Company Share by Revenue ($ mn), 2006-2007
    • Table 121: In Vitro Diagnostics, China, Overall Revenue ($ mn), 2000-2015
    • Table 122: In Vitro Diagnostics, China, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 123: In Vitro Diagnostics, China, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 124: Blood Test Reagents, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 125: Clinical Chemistry Test Reagents, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 126: Genetic Test Reagents, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 127: Immunochemistry Test Reagents, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 128: Infectious Immunology Test Reagents, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 129: Instruments, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 130: Microbiology Test Reagents, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 131: Self Testing, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 132: In Vitro Diagnostics, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 133: Blood Test Reagents, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 134: Clinical Chemistry Test Reagents, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 135: Genetic Test Reagents, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 136: Immunochemistry Test Reagents, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 137: Infectious Immunology Test Reagents, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 138: Instruments, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 139: Microbiology Test Reagents, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 140: Self Testing, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 141: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015
    • Table 142: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 143: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 144: Blood Test Reagents, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 145: Clinical Chemistry Test Reagents, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 146: Genetic Test Reagents, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 147: Immunochemistry Test Reagents, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 148: Infectious Immunology Test Reagents, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 149: Instruments, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 150: Microbiology Test Reagents, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 151: Self Testing, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 152: In Vitro Diagnostics, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 153: Blood Test Reagents, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 154: Clinical Chemistry Test Reagents, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 155: Genetic Test Reagents, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 156: Immunochemistry Test Reagents, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 157: Infectious Immunology Test Reagents, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 158: Microbiology Test Reagents, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 159: Self Testing, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 160: In Vitro Diagnostics, Canada, Overall Revenue ($ mn), 2000-2015
    • Table 161: In Vitro Diagnostics, Canada, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 162: In Vitro Diagnostics, Canada, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 163: Blood Test Reagents, Canada, Distribution Share by Revenue ($mn), 2007-2008
    • Table 164: Clinical Chemistry Test Reagents, Canada, Distribution Share by Revenue ($mn), 2007-2008
    • Table 165: Genetic Test Reagents, Canada, Distribution Share by Revenue ($mn), 2007-2008
    • Table 166: Immunochemistry Test Reagents, Canada, Distribution Share by Revenue ($mn), 2007-2008
    • Table 167: Infectious Immunology Test Reagents, Canada, Distribution Share by Revenue ($mn), 2007-2008
    • Table 168: Instruments, Canada, Distribution Share by Revenue ($mn), 2007-2008
    • Table 169: Microbiology Test Reagents, Canada, Distribution Share by Revenue ($mn), 2007-2008
    • Table 170: Self Testing, Canada, Distribution Share by Revenue ($mn), 2007-2008
    • Table 171: In Vitro Diagnostics, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 172: Blood Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 173: Clinical Chemistry Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 174: Genetic Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 175: Immunochemistry Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 176: Infectious Immunology Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 177: Self Testing, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 178: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015
    • Table 179: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 180: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 181: Blood Test Reagents, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 182: Clinical Chemistry Test Reagents, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 183: Genetic Test Reagents, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 184: Immunochemistry Test Reagents, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 185: Infectious Immunology Test Reagents, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 186: Instruments, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 187: Microbiology Test Reagents, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 188: Self Testing, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 189: In Vitro Diagnostics, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 190: Blood Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 191: Clinical Chemistry Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 192: Genetic Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 193: Immunochemistry Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 194: Infectious Immunology Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 195: Microbiology Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 196: Self Testing, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 197: In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015
    • Table 198: In Vitro Diagnostics, India, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 199: In Vitro Diagnostics, India, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 200: Blood Test Reagents, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 201: Clinical Chemistry Test Reagents, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 202: Immunochemistry Test Reagents, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 203: Infectious Immunology Test Reagents, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 204: Instruments, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 205: Microbiology Test Reagents, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 206: In Vitro Diagnostics, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 207: Blood Test Reagents, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 208: Clinical Chemistry Test Reagents, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 209: Immunochemistry Test Reagents, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 210: Infectious Immunology Test Reagents, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 211: Instruments, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 212: Microbiology Test Reagents, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 213: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015
    • Table 214: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 215: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 216: Blood Test Reagents, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 217: Clinical Chemistry Test Reagents, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 218: Genetic Test Reagents, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 219: Immunochemistry Test Reagents, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 220: Infectious Immunology Test Reagents, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 221: Instruments, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 222: Microbiology Test Reagents, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 223: Self Testing, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 224: In Vitro Diagnostics, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 225: Blood Test Reagents, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 226: Clinical Chemistry Test Reagents, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 227: Genetic Test Reagents, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 228: Immunochemistry Test Reagents, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 229: Infectious Immunology Test Reagents, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 230: Microbiology Test Reagents, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 231: Self Testing, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 232: Beckman Coulter, Inc. Pipeline Products by Equipment Type
    • Table 233: Beckman Coulter, Inc. Pipeline Products By Development Stage
    • Table 234: Beckman Coulter, Inc. Pipeline Products By Therapy Area
    • Table 235: Beckman Coulter, Inc. Pipeline Products By News Summary
    • Table 236: Gen-Probe Incorporated Pipeline Products by Equipment Type
    • Table 237: Gen-Probe Incorporated Pipeline Products By Development Stage
    • Table 238: Gen-Probe Incorporated Pipeline Products By Therapy Area
    • Table 239: Gen-Probe Incorporated Pipeline Products By Clinical Trials
    • Table 240: Gen-Probe Incorporated Pipeline Products By News Summary
    • Table 241: Genzyme Corporation Pipeline Products by Equipment Type
    • Table 242: Genzyme Corporation Pipeline Products By Development Stage
    • Table 243: Genzyme Corporation Pipeline Products By Therapy Area
    • Table 244: Genzyme Corporation Pipeline Products By Clinical Trials
    • Table 245: Genzyme Corporation Pipeline Products By News Summary
    • Table 246: Olympus Medical Systems Corp. Pipeline Products by Equipment Type
    • Table 247: Olympus Medical Systems Corp. Pipeline Products by Development Stage
    • Table 248: Olympus Medical Systems Corp. Pipeline Products by Therapy Area
    • Table 249: Olympus Medical Systems Corp. Pipeline Products by Clinical Trials
    • Table 250: Olympus Medical Systems Corp. Pipeline Products by News Summary
    • Table 251: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type
    • Table 252: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
    • Table 253: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
  • 1.2 List of Figures
    • Figure 1: In Vitro Diagnostics Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 2: In Vitro Diagnostics, Global, Overall Revenue ($ mn), 2000-2015
    • Figure 3: In Vitro Diagnostics, Global, Cross-Category Analysis, 2000-2015
    • Figure 4: In Vitro Diagnostics, Global, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 5: In Vitro Diagnostics, Global, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 6: In Vitro Diagnostics, Global, Company share (%), 2007
    • Figure 7: In Vitro Diagnostics, United States, Overall Revenue ($ mn), 2000-2015
    • Figure 8: In Vitro Diagnostics, United States, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 9: In Vitro Diagnostics, United States, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 10: In Vitro Diagnostics, United States, Company Share (%), 2007
    • Figure 11: Blood Test Reagents, United States, Company Share (%), 2007
    • Figure 12: Clinical Chemistry Test Reagents, United States, Company Share (%), 2007
    • Figure 13: Genetic Test Reagents, United States, Company Share (%), 2007
    • Figure 14: Immunochemistry Test Reagents, United States, Company Share (%), 2007
    • Figure 15: Infectious Immunology Test Reagents, United States, Company Share (%), 2007
    • Figure 16: Microbiology Test Reagents, United States, Company Share (%), 2007
    • Figure 17: Self Testing, United States, Company Share (%), 2007
    • Figure 18: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015
    • Figure 19: In Vitro Diagn???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????